Samsung Biologics Conducts Executive Personnel Changes... 4 Promoted to Managing Director

Samsung Biologics announced on the 30th that it has conducted its executive personnel appointments for 2024.

Based on a performance-oriented principle, a total of four new executives were appointed in this personnel reshuffle. Executive Director Yoon Jong-gyu was recognized for leading maximum sales achievement through efficient production volume management as the head of the Manufacturing Planning Team. Executive Director Lee Sang-myung, in charge of business operations and planning, contributed to stable operations by minimizing business risks. Executive Director Cho Sung-hwan, as the head of the GA Team, enhanced the company's competitiveness by generating results in external cooperation and infrastructure sectors. Female leader Executive Director Hong Yeon-jin, serving as the head of the QA Team, is successfully driving the strengthening of quality capabilities and the advancement of the quality system.

Samsung Biologics plans to strengthen its personnel policy of selecting and nurturing young talents who demonstrate performance and potential regardless of age or seniority. Through this, the company aims to further accelerate growth, including overseas expansion and business portfolio diversification.

Following this regular executive personnel appointment, Samsung Biologics will soon announce organizational restructuring and position appointments.

Below is the list of promoted executives.

▲Yoon Jong-gyu ▲Lee Sang-myung ▲Cho Sung-hwan ▲Hong Yeon-jin

Samsung Biologics Executive Directors Yoon Jong-kyu, Lee Sang-myung, Cho Sung-hwan, Hong Yeon-jin. (From left) [Photo by Samsung Biologics]

This content was produced with the assistance of AI translation services.